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Summary.-Lymphocytes from patients with neoplastic disease were tested for
sensitization to encephalitogenic factor (EF) by the macrophage migration
inhibition test. Sensitization to EF was demonstrated in710% ofpatientswithvarious
forms of neoplastic disease. Sensitization to EF was also demonstrated for 310% of
subjects with no evidence of neoplastic disease; these included patients with warts,
chronic bronchitis and hernias. In contrast, healthy subjects showed no sensitiza-
tion to myelin basic protein. These observations suggest that sensitization to EF
may not be confined to patients with neoplastic disease.
Lymphocytes from hamsters bearing a transplanted virus induced tumour were
sensitized to EF prepared from both human and hamster brain. Sensitization was
also seen in hamsters infected with influenza virus but not in animals with acute
tubular necrosis produced by glycerol treatment. The development of an animal
model system provides a method for the investigation of possible mechanisms of
sensitization.
THE RESPONSE of sensitized lympho-
cytes to encephalitogenic factor (EF) and
cancer basic protein forms the basis of an
in vitro laboratory technique for the
detection of malignant disease (Field and
Caspary, 1970; Pritchard et al., 1973;
Goldstone, Kerr and Irvine, 1973).
Thus, lymphocytes from patients with
neoplastic disease interact with antigen to
release a macrophage slowing factor (MSF)
which can be demonstrated by the macro-
phage electrophoretic mobility (MEM)
test. Theresultshaveshownthatpatients
with neoplastic disease are sensitized to
EF; however, sensitization could also be
demonstrated in some patients with mult-
iple sclerosis, chronic bronchitis and
asthma (Field, Caspary and Smith, 1973).
We have found the test difficult to stand-
ardize and beset by technical problems.
The evidence for sensitization to EF in
patients with neoplastic disease is increas-
ing but the application and investigation
of this sensitization could begreatly facili-
tated if a more convenient test could be
found.
Since the sensitization of lymphocytes
to antigen can be demonstratedbymeasur-
ing the release of macrophage migration
inhibition factor (MIF), we have studied
sensitization to EF by the macrophage
migration inhibition (MMI) test (George
and Vaughan, 1962; David et al., 1964).
Lymphocytes from patients with neo-
plastic disease, a variety of other con-
ditions and from healthy subjects have
been used. In order to study the
mechanism of sensitization, the response
to EF was examined in hamsters bearing
a transplanted virus induced tumour,
in hamsters convalescent from influenza
virus infection and following glycerol
treatment which induced acute renal
tubular necrosis.CELLULAR IMMUNITY TO MYELIN BASIC PROTEIN
MATERIALS AND METHODS
A. Patients and controls
The subjects tested in the present study
were taken from a variety of sources and
each subject was studied ononly one occasion.
The patients with "cancer" included both in-
patients and out-patients; in all cases the
diagnosis had been established histologically.
Many of the patients had undergone surgery
or other treatment, but none had received
recent radiotherapy or chemotherapy. The
control subjects were out-patients or members
of the hospital or laboratory staff.
Ten ml of venous blood was collected
from each subject and placed in Searle-LH/10
lithium-heparin containing vials (Searle
Diagnostics, Wycombe). Lymphocytes were
harvested from the blood by the Ficoll-Triosil
gradient separation method (Pritchard et al.,
1973), and were washed 3 times with medium
199 (WellcomeLaboratoriesLtd, Beckenham).
Macrophage migration inhibition test.-Peri-
toneal exudate cells (PEC) were collected
from Hartley guinea-pigs (250-350 g), 10
days after intraperitoneal stimulation with
20 ml of sterile liquid paraffin, and prepared
as described previously (Rees and Potter,
1973). In the original tests, PEC were sub-
jected to irradiation with 250 rad X-rays;
however, it was later found that any mixed
lymphocyte reaction that might occur did
not alter the test significantly, and for the
latter tests the cells were not irradiated. A
mixed suspension oflymphocytes and macro-
phages was prepared to give a final concentra-
tion of cells of 2 x 106/ml and 1 x 107/ml res-
pectively (Marsman and Van der Hart 1973).
The cell suspension was drawn into 10,ul
glass microcaps (Drummond Scientific Co.,
U.S.A.), sealed with Cristoseal (Hawkesley
and Sons Ltd) and centrifuged at 500 g for
5 min. After trimming the excess tubing,
the microcaps were anchored with silicone
grease in Sterilin wells and incubated in
medium 199 containing 10% heat-inactivated
foetal calf serum and encephalitogenic factor
(EF) at a concentration of 01 mg/ml. The
EF was prepared from normal human brain
by acid extraction, followed by high speed
centrifugation and subsequent freeze-drying;
no attempt was made to purify the extract
further (Caspary and Field, 1971). Duplicate
wells were set up containing no EF, and an
additional control was included with PPD at
a concentration of 20,ug/ml (Hughes, 1972).
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Two to 4 wells each containing 3 capillary
tubes were set up for each treatment. Every
well was sealed with a glass coverslip, fixed
with silicone grease and incubated at 370C in
an atmosphere containing 5% CO2/95% air.
The areas of migration were calculated by
projection on to graph paper and subsequent
counting of squares. The percentage inhib-
ition of migration was calculated from the
formula:
% Inhibition =
1001 Area of migration with antigen Area of migration without antigen)
The statistical significance of the results
was calculated using Student's t tests.
B. Animal systems
Sensitization to EF was examined in
Syrian hamsters subjected to a variety of
experimental procedures. The animals were
all obtained from accredited dealers and
were 60-80 g in weight.
SV40 induced tumour.-A transplanted SV
40virusinducedtumourofhamsterswasused;
this tumour was originally induced by the
inoculation of SV40 virus into a newborn
hamster and maintained for the past 3 years
in this laboratory by passage at 2-3 week
intervals. Excised tumours were removed,
freed of necrotic tissue, chopped finely with
scalpels and treated with 0.25% trypsin to
obtain a single cell suspension (Rees and
Potter, 1973). Cells were washed twice with
Eagle's minimal essential medium and resus-
pended to a concentration of 105 viable
cells/ml. Two groups of 8 hamsters were
each inoculated subcutaneously with 104
SV40 induced tumour cells and the animals
killed 10 and 17 days later when the tumours
were 3-4 cm in diameter.
Influenzavirusinfectedhamsters.-Influenza
virus A/FM/1/47 (HlNl) was prepared by
allantoic inoculation of 10-day embryonated
eggs with 10-3 dilution of stock virus. After
incubation for 48 h at 350C, the allantoic
fluids were harvested, pooled and stored at
-80°C. The virus pool had a titre of 108.5
EID50/ml. Groups of hamsters were lightly
anaesthetized with ether and each animal
inoculated intranasally with 0-2 ml of virus.
This dose produced no clinical signs of influ-
enza infection but virus could be recovered
from the lungs and nasal washings and high
titres of serum antibody were produced.
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Groups of 8 hamsters were killed at approx-
imately weekly intervals for 3 weeks, together
with 8 normal, uninfected animals.
Cellular necrosis in hamsters.-Glycerol
induced acute tubular necrosis (Finckh, 1957)
was selected as an experimental situation
where considerable cell death had occurred.
Subcutaneous administration of glycerol to
rats results in a haemolytic crisis (Cameron
and Finckh, 1956) followed by severe necrosis
ofrenaltubules 2-3 days afterinjection. The
kidney tubules have largely regenerated
after 5 days, but complete restoration to a
histologically normal kidney requires 6-12
weeks. A similar histological pattern was
demonstrated in hamsters after glycerol
treatment. In the present experiments, a
group of 8 hamsters were injected subcutan-
eously with 1-0 ml of glycerol (BP). The
animals were killed 10 days later.
Macrophage migration tests in hamsters.-
Groups of 8 hamsters were killed and the
spleens removed and pooled. After brief
homogenization in medium 199, the spleen
fragments were filtered through sterile cotton
gauze and the filtrate centrifuged at 1000 g
for 10 min. Red blood cells were flash lysed
by the addition of distilled water to the cell
pellet for 20 s; after this time the suspension
was returned to isotonicity by the addition
of an equal volume of 0 3 mol/l NaCl. The
cellsuspension waswashed 3 times in medium
199 and added to guinea-pig peritoneal exud-
ate cells (PEC) to give a final concentration
of2 x 106/ml viable spleen cells and 1 X 107/
ml PEC. The MMI test was then set up as
previously described using EF from human
brain as antigen but omitting PPD as a con-
trol. Cellular immunity of spleen cells from
SV40 tumour bearing hamsters was also
investigated using SV40 tumour antigen
and EF prepared from hamster brain white
matter. The SV40 tumour antigen was pre-
pared by the method of Rees and Potter
(1973). This extract was subsequently cen-
trifuged at 3000 rev/min for 20 min, and the
supernatent used at a fixed concentration
of 10% (v/v). The hamster brain EF was
prepared as described for the preparation of
human EF (Caspary and Field, 1971).
RESULTS
A. Sensitization to EF in patients and
controls
Sensitization to EF, as demonstrated
by the MMI test, was investigated in a
total of 208 subjects. The results are
shown in Tables I, II, III and IV. Table
I shows the data from 13 patients with
carcinoma of the upper respiratory tract.
Twelve of the 13 patients show sensitiz-
ation to EF with a range of inhibition
from 20 to 49. Lymphocytes from a total
of 124 patients with proven neoplastic
disease were tested for sensitization to
EF (Table II). A significant inhibition
(P <0.01) of macrophage migration
in the presence of EF was observed for
lymphocytes from 88 (71%) of the pat-
ients; inhibition at the level ofP <0 05
was not considered significant, and results
at this level ofinhibition were included in
the negative results. The percentage of
patients sensitized to EF varied for
different forms of neoplastic disease.
Thus, 30 of 33 patients (91%) with car-
TABLE I.-Sensitization to EF in 13 Patients with Upper Respiratory Tract Carcinomata
Area of migration
+EF±SD -EF±SD
60±3*6 93±5- 2
63±7 2 105±7-7
54±3-9 92±4 1
19±5-2 35±4-9
20±3 0 34±4 7
25±3-1 48±8-8
45±2-5 82±8 8
32+1-5 40±1-3
45±5- 6 84±6-1
70±1 2 86±1-2
65±5-4 71±7-4
70±4 8 87±3-3
45±2-7 71±9-8
% Inhibition
37
36
41
44
40
49
45
20
46
22
9
20
36
Level of significance
< 0-001
< 0.001
< 0.001
< 0.001
< 0.001
< 0-001
< 0-001
< 0*001
< 0-001
< 0.001
n.s.
< 0.001
< 0-001
Patient No.
1
2
3
4
5
6
7
8
9
10
11
12
13
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TABLE II.-Sensitization to EF in 124 Patients with Malignant Disease
Sex
Site or type Total no. - -
of tumour of patients F M Age
Ca gastro-
intestinal tract
Ca cervix,
uterus, ovary
Ca testes
Ca breast
Ca lung,
bronchus
Ca bladder
Ca buccal cavity
pharynx, larynx
Lymphoma
Leukaemia
5 1 4 52-57
12 12 35-65
8
26
20
8 28-60
26 41-73
6 14 48-70
25 10 15
13 3 10 49-83
12
3
124
7
1
66
5
2
58
30-74
30-64
28-83
Significant inhibition with No significant inhibition
EF(P<0.01) withEF
Total % Inhibition
3 39-50
9
4
16
18
17
12
9
0
88(71 %)
18-53
29-40
27-54
29-56
22-62
20-49
26-44
Total % Inhibition
2 17-20
3 (-15)-0
4
10
2
0-24
(-15)-7
1-4
8 (-18)-6
1 9
3 6-11
3 0-12
36(29%)
TABLE III.-Sensitization to EF in 19 Healthy Donors
Significant inhibition with
EF (P < 0-01)
Total % Inhibition
0
No significant inhibition
with EF
r-
- A
Total % Inhibition
19 (100%) (-12)-10
TABLE IV.-Sensitization to EF in 65 Patients with Various Non-malignant Disorders
Sex
Diagnosis Total no.
of patients F M
'arts 11 1 10
ironic 4 4
bronchitis
Hernia
Multiple
sclerosis
Other non-
malignant
conditions*
Significant inhibition with
EF (P < 0.01)
Total % Inhibition
7 21-63
2 20-32
5 1 4 3
8 6 2 1
37 20 17
36-49
42
7 22-63
65 28 37 20(31%)
No significant inhibition
with EF
Total % Inhibition
4 (-3)-21
2 0,14
2
7
30
45(69%)
(-19), 5
3-20
(-16)-30
* Group includes patients with diverticulitis, varicose veins, fibroadenoma of breast, mastitis, nonspecific
urethritis, pneumonia, asthma, glandular fever, jaundice, gallstones, haemorrhoids and ulcers.
cinoma of the upper respiratory tract,
bronchus or lung were sensitized to EF
whereas only 25 of 38 (66%) of patients
with carcinoma of breast, cervix, uterus
or ovary were sensitized.
Lymphocytes from 19 healthy control
subjects were tested for sensitization to
EF by the MMI test; no evidence of
sensitization was found for any of these
subjects (Table III).
Lymphocytes from a total of 65 sub-
jects with conditions other than neoplastic
disease were tested for sensitization to
EF. The results are shown in Table IV.
Significant inhibition of macrophages
(P < 0.01) was observed for lympho-
cytes from 7 of 11 patients with warts,
2 of 4 patients with chronic bronchitis,
3 of 5 patients with hernias and one of
8 patients with multiple sclerosis. In
addition, 7 patients with a variety of
conditions were also sensitized to EF
(Table IV). Of a total of 65 patients in
these groups, lymphocytes from 20 (31%)
showed significant sensitization to EF
(P < 0-01).
Total
19
Sex
M F
11 8
WI
Ch
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TABLE V.-Production of MIF by Spleen Cellsfrom Tumour Bearing and Normal
Hamsters
Result of macrophage migration inhibition test
Source of spleen cells
Tumour bearing
hamsters
Normal hamsters
Tumour bearing
hamsters
Normal hamsters
Human EF
EF Area %
(iSD)
+ 61*8±1*9 34*
- 93-0±6-1
+ 46-4±4-2 4
- 48-3±4-8
+ 15-7±2-9 62*
- 422±2-27
+ 49 3±0 9 0
- 500±59
Hamster EF
EF Area %
(iSD)
+
SV40 antigen
A.gen Area %
(±SD)
+ 21*0+1-8 58*
- 50-8±5-1
+ 29-5±6-2
- 26-1±2-6
22-9i4-49 49*
42- 22 7
52*0i±08 0
50 0±5 9
* Significant inhibition (P <0 001) of macrophage migration.
TABLE VI.-Production of MIF by Spleen Cellsfrom Hamstersfollowing Influenza
Infection and Normal Hamsters
Days after infection Source of spleen cells
Influenza infected
hamsters
Normal hamsters
Influenza infected
hamsters
Normal hamsters
Influenza infected
hamsters
Normal hamsters
Macrophage migration area ±SD
+EF -EF
42-0±4-5
46-2±3-6
34 3±7 0
42-5*5-0
27-7±2-9
32*6+2*2
73 2+3 4
41 5±3-6
53 5±3 0
41 4±4-5
45-3±4- 7
35-2±3-1
* Significant Inhibition (P <0 -001).
TABLE VII.-Production of MIF by Spleen Cellsfrom Hamsters with Acute
Tubular Necrosis and Normal Hamsters
Days after glycerol
treatment
10
Source of spleen cells
Hamsters with acute
tubular necrosis
Normal hamsters
Macrophage migration area i SD
+EF -EF
33-0±1-6 33-2±0-8
42-0±6 5 43-2+4 6
B. Sensitization to EF in hamsters
(1) Tumour bearing animals.-Spleen
cells from hamsters bearing transplanted
SV40 virus induced tumours were tested
for sensitization to EF or SV40 tumour
antigen by the MMI test. The results are
shown in Table V. Spleen cells tested
10 or 17 days after tumour cell inoculation
were sensitized to human EF, since these
cells incubated in the presence of EF
resulted in significant inhibition of macro-
phage migration (P < 0.001). This
result was obtained in 3 separate experi-
ments, only one of which is shown in
Table V. In addition, spleen cells from
tumour bearing hamsters were sensitized
to EF prepared from hamster brain, and
to SV40 tumour antigen (P < 0-0001).
Spleen cells from normal hamsters were
notsensitizedtoanyofthesethreeantigens.
(2) Influenza infected hamsters.
Macrophage migration inhibition tests
were carried out using spleen cells from
hamsterspreviouslyinfectedwithinfluenza
Days after
transplant
10
17
9
14
21
% Inhibition
44*
0
36*
-2
39*
7
% Inhibition
0
2
t
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virus A/FM/1/47. The results are shown
in Table VI. Spleen cells tested 9, 14 and
21 days after infection were found to be
sensitized to human EF; in each case
significant inhibition of macrophage
migration (P < 0001) was observed.
Spleencellsfromgroupsofnormalhamsters
tested in parallel were not sensitized to
human EF.
(3) Glycerol treated hamsters. Spleen
cells from hamsters 10 days after glycerol
treatment were tested for sensitization to
human EF; this treatment produced an
acute tubular necrosis. The results are
shown in Table VII. No evidence of
sensitization was demonstrable in these
animals since spleen cells did not produce
MIF when incubated with EF.
DISCUSSION
Sensitization to EF in patients with
nepolastic disease has been demonstrated
using the MEM test by Field and Caspary
(1970) and Pritchard et al. (1973). How-
ever, this test is complex and difficult to
standardize, and our results using the
MEM test are not as consistent as those
of other workers; this has prohibited its
use in a conventional hospital situation.
Macrophage slowing factor (MSF) and
macrophage inhibiting factor (MIF) are
both products liberated from sensitized
lymphocytes when incubated in the
presence of specific antigen. It would be
expected that results obtained with the
two tests would be similar but not neces-
sarily identical, The MMI test was sel-
ected for the present study since it is
rapidly accomplished and has been stand-
ardized for a number of parameters such
as pH, temperature and incubation period
(Hughes, 1972). In addition, the MMI
test has been used extensively in this lab-
oratory as a reliable method for the
detection of delayed hypersensitivity to
virus induced tumour antigens (Rees and
Potter, 1973; Rees et al., 1975). In the
present study, cell mediated immunity to
EF has been examined in human subjects
by the macrophage migration inhibition
(MMI) test, and 71% of patients with
neoplastic disease, 310% of patients with
non-malignant conditions and none of 19
healthy persons were found to be sensit-
ized to human myelin protein.
The demonstration of sensitization to
EF in 71% of patients with neoplastic
disease is lower than the figures reported
by other workers (Pritchard et al., 1973;
Field et al., 1973). This may be due to
the stringency of our statistical interpret-
ation. In the present study, sensitization
to EF was taken only when the degree of
macrophage inhibition was at the level of
P < 0-01; values of P 0-05-0-01 were
not considered significant. ln fact, when
the level of significance is raised to 500 (P
-0 05)770 ofpatientswithneoplastic dis-
easearesensitizedtoEFbut45 oofpatients
with non-malignant diseases are also
sensitized to EF; the healthy controls all
remain negative. Thus, at the level of
P <0-01 there is a greater separation
of the neoplastic and non-neoplastic
groups. In addition, the fairly small
sample size necessitates stringent criteria.
An alternative explanation to account
for the low percentage of negative results
in patients with neoplastic disease is that
the MMI test is less sensitive than the
MEM test (Hughes and Paty, 1971). Our
results in a number of subjects with non-
malignant diseases are not in accord with
this explanation. Thus, sensitization was
demonstrated for some patients with
multiple sclerosis, chronic bronchitis,
warts and hernias; sensitization to EF in
patients with multiple sclerosis, Crohn's
disease, ulcerative colitis, asthma and
sarcoidosis has been reported previously
(Field et al., 1973). These results indicate
that sensitization to EF is not confined to
patients with neoplastic disease but is part
of a more general immune reaction.
An animal model system would provide
an experimental basisfortestingtheunder-
lying mechanism of EF sensitization. In
the present study, we have demonstrated
cell mediated immunity to EF in hamsters
bearing transplanted SV40 virus induced
tumours. In addition, sensitization to
EF occurred in hamsters following influ-
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enza infection and sensitization has been
reported for patients following influenza
(Field et al., 1973). Our findings in some
patients and in hamsters suggest that a
disease process which results in cellular
degeneration may cause a release of basic
proteins similar or identical to EF and
subsequent sensitization. However, we
were unable to demonstrate sensitization
in all patients where cellular degeneration
may occur, or in hamsters with acute
tubular necrosis following glycerol treat-
ment. Since an analogy can be drawn,
it is hoped that the animal model system
will clarify the immunological basis of
sensitization to myelin basic protein in
man.
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